Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer.

Robinson, M; O'Cathail, S; Duffton, A; Aitken, K; Muirhead, R

Robinson, M; O'Cathail, S; Duffton, A; Aitken, K; Muirhead, R.

Robinson M; Oxford University Hospitals NHS Trust, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK. Electronic address: Maxwell.Robinson@oncology.ox.ac.uk.
O'Cathail S; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Beatson West of Scotland Cancer Centre, Glasgow, UK.
Duffton A; Beatson West of Scotland Cancer Centre, Glasgow, UK.
Aitken K; Royal Marsden NHS Trust, London, UK; Institute of Cancer Research, London, UK.
Muirhead R; Oxford University Hospitals NHS Trust, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK.

Clin Oncol (R Coll Radiol) ; 34(9): 571-577, 2022 09.

Article en En | MEDLINE | ID: mdl-35504797

Asunto(s)

Neoplasias Pulmonares; Radiocirugia; Reirradiación; Neoplasias del Recto; Fraccionamiento de la Dosis de Radiación; Humanos; Neoplasias Pulmonares/radioterapia; Recurrencia Local de Neoplasia/etiología; Recurrencia Local de Neoplasia/radioterapia; Recurrencia Local de Neoplasia/cirugía; Calidad de Vida; Radiocirugia/efectos adversos; Reirradiación/efectos adversos; Neoplasias del Recto/radioterapia; Neoplasias del Recto/cirugía; Estudios Retrospectivos

Palabras clave

Isotoxic SABR; re-irradiation; recurrent rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Radiocirugia / Reirradiación / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google